Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | BIRC2 | Q13490 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | POLA1 | P09884 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27451629 | 1.00 | CA2 (0.56) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL7165372 | 1.00 | CA2 (0.56) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL5879370 | 0.98 | CA2 (0.58) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL29051932 | 0.93 | CA2 (0.65) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL28087826 | 0.92 | CA2 (0.62) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL671483 | 0.87 | TSHR (0.47) | CA2CA1ZDHHC7TSHRFAAH | |
| SCHEMBL9673462 | 0.87 | CPB2 (0.47) | CA2CA1ZDHHC7TSHRFAAH | |
| SCHEMBL5599769 | 0.87 | CPB2 (0.47) | CA2CA1ZDHHC7TSHRFAAH | |
| SCHEMBL11332479 | 0.86 | CA1 (0.48) | CA2CA1ZDHHC7TSHRABCB1 | |
| SCHEMBL23834150 | 0.85 | CA2 (0.54) | CA2CA1ZDHHC7TSHRABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7282605-B2 | Optically active 2-allylcarboxylic acid derivative and process for producing the same | KANEKA CORPORATION (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20060223152-A1 | Optically active 2-allylcarboxylic acid derivative and process for producing the same | KANEKA CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1650187-A1 | OPTICALLY ACTIVE 2-ALLYLCARBOXYLIC ACID DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223152-A1 | Optically active 2-allylcarboxylic acid derivative and process for producing the same | APEH, NAAA, AADAC | CA2 71/4885CA1 372/4885ZDHHC7 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.